SuperCrowd
New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
Isosceles Pharmaceuticals, Inc.
www.isoscelespharma.com · NV · Filed Oct 3, 2022
Isosceles Pharmaceuticals, Inc. filed a Form C — new offering — with the SEC on Oct 3, 2022. The Regulation Crowdfunding offering seeks $20,000, up to a maximum of $5,000,000 on Equifund Crowd .. Investors receive: Common Stock at $2.05. The offering closes Feb 10, 2023.
| Target raise | $20,000 |
|---|---|
| Maximum raise | $5,000,000 |
| Security | Common Stock @ $2.05 |
| Closes | Feb 10, 2023 |
| Portal | Equifund Crowd . |
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.